Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
164.49
+2.16 (1.33%)
At close: Mar 9, 2026, 4:00 PM EDT
164.49
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
Axsome Therapeutics Employees
Axsome Therapeutics had 925 employees as of December 31, 2025. The number of employees increased by 242 or 35.43% compared to the previous year.
Employees
925
Change (1Y)
242
Growth (1Y)
35.43%
Revenue / Employee
$690,266
Profits / Employee
-$198,026
Market Cap
8.41B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Madrigal Pharmaceuticals | 915 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Krystal Biotech | 295 |
AXSM News
- 12 days ago - Axsome Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 14 days ago - Axsome: Q4 Earnings Review: Solid Performance, But Pipeline May Be Overvalued - Seeking Alpha
- 14 days ago - Axsome Therapeutics, Inc. (AXSM) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 20 days ago - Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd. - GlobeNewsWire
- 5 weeks ago - Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23 - GlobeNewsWire
- 6 weeks ago - Axsome Therapeutics: A Conditional Buy Built On SG&A Discipline - Seeking Alpha
- 7 weeks ago - MoneyShow's Best Investment Ideas For 2026: Part 2 - Seeking Alpha